Clinical Trial Update: A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial of atezolizumab plus bevacizumab for unresectable or locoregionally unsuitable hepatocellular carcinoma in Spanish patients has been terminated; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: TERMINATED | Results posted: 2025-05-08